Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-054024
Filing Date
2025-03-13
Accepted
2025-03-13 17:05:55
Documents
6
Effectiveness Date
2025-03-13

Document Format Files

Seq Description Document Type Size
1 S-8 d897427ds8.htm S-8 66874
2 EX-5.1 d897427dex51.htm EX-5.1 7241
3 EX-23.1 d897427dex231.htm EX-23.1 1938
4 EX-FILING FEES d897427dexfilingfees.htm EX-FILING FEES 16674
5 GRAPHIC g897427dsp11.jpg GRAPHIC 11180
6 GRAPHIC g897427dsp13.jpg GRAPHIC 9821
  Complete submission text file 0001193125-25-054024.txt   112228
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285799 | Film No.: 25736734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)